Previous year, his earning was 20. The University of Miami registrar's office has been unable to confirm Mr. A quick call to the university in question will tell you if it's true or false. More likely, everyone simply relied on the word of Mr. And degrees or not, Gonzalez has proved himself sufficiently knowledgeable and politically adept to eventually become chief operating officer and to run AbbVie come January. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives.
The Board of Abbott Laboratories saw no real issue with his credentialing issue Ms. The Pharmacyclics name was retained, and it operates as a subsidiary of AbbVie from its previous , headquarters. Gonzalez's tenure as a director. Securities and Exchange Commission from 2002 to 2007, Abbott also said Mr. The board declined his offer to resign. Brotz was willing to speak out on behalf of Mr. When you make a statement, you should do your best to verify that it's true.
Two of the companies are still active while the remaining four are now listed as inactive. Yet Humira is also expected to face competition from cheaper so-called biosimilar versions of the drug by 2016. There should be no exception for senior executives. Gonzalez's, attended the University of Houston from the fall of 1972 to the fall of 1973, but was not granted a degree, according to a school spokeswoman. Gonzalez, who joined Abbott in 1977 and temporarily retired in 2007, alerted the company before his return in 2009 that his biography overstated his schooling, according to Mr. That aside, he had once taken retirement for 2 years from his job after being diagnosed with throat cancer in 2007. Since his return, Abbott has softened the details about his educational background.
Statements about educational degrees are among the most easily verifiable assertions around. Gonzalez was previously employed as Chief Executive Officer-Operations by Abbott Laboratories, President by Abbott Ventures, Inc. The implication is that his attendance at these schools was mistaken for graduation by someone — however many years ago — who listed the information in his Abbott records. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. The memo does not explain why Mr. Will this herald similar moves for other big pharma companies with diverse portfolios, in uncertain financial times when diversifying would seem to be the safer option? Abbott, which will retain its name, will maintain nutritional, medical device and generic drug business lines. Perhaps such a scenario never occurred, but how could he be unaware of the mistake for such a long period of time? White told analysts in a 90-minute conference call Wednesday morning.
So far, the Abbott explanations have fallen short. In fact, he never earned a degree anywhere. Rank-and-file employees who are found to have falsified information on job applications routinely are dismissed from their jobs. As my colleague Abbott falsely stated in nine federal filings over a six-year period that Executive Vice President Richard Gonzalez held degrees in biochemistry from the University of Houston and the University of Miami in Florida. At some point, the Abbott web site was corrected; a last year in The Chicago Tribune repeated the updated information in this story.
For 18 months leading up to his present gig, he was executive vice president of the pharmaceutical products group. It should conduct a thorough investigation to determine who provided the false information. The deal is another chapter in the comeback story of Mr. All quotes are in local exchange time. In spite of discounts and medical insurance, the prohibitive price causes some patients to not fill their prescriptions. Intraday data delayed at least 15 minutes or per exchange requirements. The companies were formed over a 111 year period with the most recent being incorporated six years ago in August of 2012.
The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. The pharmaceuticals business is generally higher risk and more focused on the United States than the devices piece. Gonzalez has to be at the top of the list of likely sources. The opinions expressed are those of the writer. And if he didn't gild his résumé himself, it's a stretch to imagine that he didn't somehow know the falsehoods were published. Clearly, he has an impressive lineup of experience.
Synlogic is a synthetic biology company built on research from the labs of and Tim Lu at. Abbott's board was advised of the problems with his biography before Mr. And all this for a man who actually retired, at least for a couple of years, in 2007. After his treatment, he returned to executive work with the company as the head of Abbott Ventures, also known as AbbVie the investment arm of the medical technology business. He deserves to have credit for the knowledge that he gained from his classroom and on the job experience.
In his current biography, Abbott now says that Mr. White, the current chairman and chief executive, will head up this company. That gain follows the drug's quarterly revenue increases of 16%, 13%, 19% and 13% in the four consecutive quarters, respectively. Abbott was called on the carpet for this. Of course, you would not just hire anybody; but remember, only a creative mind could recognize a creative mind. Gonzalez was a 30-year Abbott veteran.
Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. Abbott learned at some point — it won't say when — that Mr. When we became aware of it a while back, we corrected it promptly. And AbbVie managed to keep the needed sales of the drug strong while it pilots development of a promising hepatitis C therapy and other drugs through its pipeline. Crain's — Richard Gonzalez, who at one time claimed obtained a master's degree from the University of Miami, attended the school for just four months, records show.